-
Mashup Score: 25EuroIntervention - 2 day(s) ago
#EIJonAir – High-risk PCI in surgically ineligible patients
Source: twitter.comCategories: General Medicine NewsTweet
-
Mashup Score: 25EuroIntervention - 2 day(s) ago
#EIJonAir – High-risk PCI in surgically ineligible patients
Source: twitter.comCategories: General Medicine NewsTweet-
#EIJonAir - High-risk PCI in surgically ineligible patients https://t.co/9cPcKT4QE8
-
-
Mashup Score: 40Can a CT scan characterise and predict HALT evolution? - 7 day(s) ago
Study on hypoattenuated leaflet thickening (HALT) observed in TAVI patients and its association with clinical outcomes.
Source: eurointervention.pcronline.comCategories: General Medicine NewsTweet-
CT-based thrombus attenuation is independently associated with HALT resolution after #TAVI. Prosthesis deformation parameters (eccentricity, canting) also impact #HALT evolution. Imaging may support risk stratification and guide management. https://t.co/Tmv7fNRg3N #EAPCI https://t.co/VorYxanvzE
-
-
Mashup Score: 64
The COMPARE STEMI ONE trial evaluates an abbreviated DAPT regimen and OCT-guided revascularization in STEMI patients undergoing PCI.
Source: eurointervention.pcronline.comCategories: General Medicine NewsTweet-
COMPARE STEMI ONE is the first RCT to assess 1-month DAPT followed by prasugrel monotherapy in STEMI patients. Also evaluated OCT-guided vs. angiography-guided staged PCI for non-culprit lesions. Protocol published 👇https://t.co/tiTNbfkfqK #DAPT #STEMI #OCT #PCI #rctst https://t.co/PMv1sDgpT6
-
-
Mashup Score: 53
The PRAGUE-26 trial evaluates the clinical outcomes of catheter-directed thrombolysis versus standard anticoagulation in patients with intermediate-high risk acute pulmonary embolism.
Source: eurointervention.pcronline.comCategories: General Medicine NewsTweet-
PRAGUE-26, a prospective, academic RCT comparing outcomes of catheter-directed thrombolysis vs. anticoagulation in intermediate-high risk PE. Designed to assess efficacy, safety, and cost-effectiveness over 2 years. #PulmonaryEmbolism #EAPCI https://t.co/vDbNhC94Fq https://t.co/PjKSYixyxL
-
-
Mashup Score: 38
This study explores the limitations of contemporary coronary intervention strategies and the role of coronary inflammation in the natural history of atherosclerosis.
Source: eurointervention.pcronline.comCategories: General Medicine NewsTweet-
A new Editorial to read on EIJ 👉 "Using pericoronary fat attenuation to guide management after coronary interventions" @charis_antoniad #EAPCI https://t.co/INaFN9Fwsz Original Article by Naniwa S. et al: https://t.co/Ge1c5vshbS https://t.co/QeD5PM84Oq
-
-
Mashup Score: 37
This study explores the limitations of contemporary coronary intervention strategies and the role of coronary inflammation in the natural history of atherosclerosis.
Source: eurointervention.pcronline.comCategories: General Medicine NewsTweet-
A new Editorial to read on EIJ 👉 "Using pericoronary fat attenuation to guide management after coronary interventions" @charis_antoniad #EAPCI https://t.co/INaFN9Fwsz Original Article by Naniwa S. et al: https://t.co/Ge1c5vshbS https://t.co/QeD5PM84Oq
-
-
Mashup Score: 43
Comprehensive overview of advancements in interventional cardiology, including coronary, valvular, heart failure, and peripheral interventions.
Source: eurointervention.pcronline.comCategories: General Medicine NewsTweet-
IDEAL-LM 5-year results: In patients undergoing PCI for left main disease, biodegradable-polymer DES + 4mo DAPT showed no advantage over durable-polymer DES + 12mo DAPT. MACE, MI, TVR, and ST rates were similar. #EAPCI #LMPCI #DES #DAPT https://t.co/DIl6lav6wg https://t.co/yBmt6YsoNs
-
-
Mashup Score: 54
Ticagrelor monotherapy after short DAPT was associated with similar ischaemic and bleeding risks compared to standard ticagrelor-based DAPT in chronic coronary syndrome patients undergoing PCI.
Source: eurointervention.pcronline.comCategories: General Medicine NewsTweet-
In patients with CCS undergoing PCI, ticagrelor monotherapy after 3 months of DAPT showed similar 1-year ischaemic and bleeding outcomes compared to ticagrelor-based #DAPT, regardless of high ischaemic risk status. @mauro_gitto https://t.co/OQBkrFoWHB #EAPCI #TWILIGHTTrial https://t.co/ZEloEmOYWg
-
-
Mashup Score: 24One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial - 29 day(s) ago
Find out more about this article on One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Source: eurointervention.pcronline.comCategories: General Medicine NewsTweet-
This Late-Breaking Trial has been published in EuroIntervention on the occasion of #EuroPCR. Read it here ➡️ https://t.co/hOeLmlxLYk➡️ https://t.co/hOeLmlxLYk https://t.co/FQ4g6XH04u
-
#EIJonAir - High-risk PCI in surgically ineligible patients https://t.co/9cPcKT4QE8